SCHEMBL19082251

SCHEMBL19082251

c1ccc(-c2c3ccccc3c(-c3cccc(-c4cc5c(sc6ccc7ccccc7c65)c5c4sc4ccccc45)c3)c3ccccc23)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 2/20 0.34
NQO1 P15559 1/20 0.34
CYP1A1 P04798 1/20 0.34
CYP1B1 Q16678 1/20 0.34
PTPN1 P18031 2/20 0.34
ALOX5 P09917 1/20 0.34
LIMK1 P53667 1/20 0.32
TNKS O95271 1/20 0.32
TNKS2 Q9H2K2 1/20 0.32
F9 P00740 1/20 0.32
KDM4E B2RXH2 2/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
PTPRC P08575 1/20 0.31
PTPRF P10586 1/20 0.31
PTPRA P18433 1/20 0.31
PTPRB P23467 1/20 0.31
PTPN6 P29350 1/20 0.31
DUSP3 P51452 1/20 0.31
PTPN12 Q05209 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17945517 0.86 TNKS (0.42) PTPN1ALOX5LIMK1TNKSTNKS2
SCHEMBL19080237 0.85 CYP1A1 (0.37) NQO2NQO1CYP1A1CYP1B1ALOX5
SCHEMBL17944815 0.85 ALOX5 (0.41) NQO2NQO1CYP1A1CYP1B1ALOX5
SCHEMBL19077284 0.85 NQO1 (0.33) NQO2NQO1CYP1A1CYP1B1PTPN1
SCHEMBL19082235 0.85 NQO2 (0.35) NQO2NQO1CYP1A1CYP1B1PTPN1
SCHEMBL19082314 0.84 ALOX5 (0.35) NQO2NQO1CYP1A1CYP1B1PTPN1
SCHEMBL17944631 0.83 ALOX5 (0.40) PTPN1ALOX5TNKSTNKS2MAPT
SCHEMBL19082232 0.83 PTPN1 (0.38) NQO2NQO1CYP1A1CYP1B1PTPN1
SCHEMBL17945265 0.83 ALOX5 (0.40) NQO2NQO1CYP1A1CYP1B1PTPN1
SCHEMBL17945082 0.83 TNKS (0.39) PTPN1ALOX5TNKSTNKS2PTPRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 NQO2 2592/4885NQO1 576/4885CYP1A1 184/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 NQO2 2592/4885NQO1 576/4885CYP1A1 184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.